CHI Advisors’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

CHI Advisors’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,782,756	Closed	-$46.9M	–	31
2023 Q2	$46.9M	Sell	2,782,756 -2,472,728	-47%	-$32.5M	14.24%	3
2023 Q1	$44.7M	Sell	5,255,484 -237,409	-4%	-$1.96M	11.87%	3
2022 Q4	$47.6M	Buy	5,492,893 +1,373,321	+33%	+$11.1M	12.68%	3
2022 Q3	$24.7M	Buy	4,119,572 +337,373	+9%	+$1.83M	6.65%	5
2022 Q2	$20.4M	Buy	3,782,199 +697,889	+23%	+$3.76M	7.8%	5
2022 Q1	$14.5M	Buy	3,084,310 +408,902	+15%	+$2.14M	6.18%	5
2021 Q4	$13.1M	Buy	2,675,408 +82,806	+3%	+$408K	4.36%	6
2021 Q3	$20M	Buy	2,592,602 +6,616	+0.3%	+$56.7K	5.85%	5
2021 Q2	$30.2M	Buy	+2,585,986	New	+$39.3M	7.01%	5

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $251M AUM 32.13% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

CHI Advisors's VECT Position: Q3 2023 in Review

CHI Advisors sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 2,782,756 shares — an estimated $46.9M sold.

CHI Advisors first reported a position in VECT in Q2 2021 and held it in 9 quarters. The position peaked at $47.6M in Q4 2022. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

CHI Advisors reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
CHI Advisors sold 2,782,756 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $46.9M.
CHI Advisors first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 9 quarters.
CHI Advisors's VectivBio Holding AG Ordinary Shares position peaked at $47.6M in Q4 2022.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.